As people's living standards improve, pets are playing an increasingly important role in families. The first Asian Small Animal Oncology Congress, held in Wuxi at the end of October 2024, was undoubtedly a significant event. The gathering of numerous domestic and international oncology experts underscores the rising incidence of small animal cancers and reflects the growing public awareness and concern for animal health.

Current Status of Animal Tumor Diagnosis and Treatment

This conference made people realize that the current methods for diagnosing and treating animal tumors are still imperfect, a situation that has prompted much reflection.

In terms of diagnosis, existing diagnostic methods do have certain limitations in the pathological assessment of animal tumors. Commonly used imaging examinations such as X-rays, ultrasound, CT scans, and MRI, while capable of detecting the presence of tumors and determining their location, size, and shape, often struggle to accurately determine the pathological type of the tumor. For example, these examinations may fail to differentiate between benign and malignant tumors, and are also unable to determine the specific cellular origin and degree of differentiation of the tumor.

Cytological examination and histopathological examination are currently the most accurate diagnostic methods, but they also have some limitations. Cytological examination typically requires the collection and analysis of tumor cell samples, but obtaining these samples can be difficult, and the accuracy of cytological examination is affected by sample quality and the experience of the analysts. Histopathological examination requires obtaining tumor tissue samples through surgery or biopsy, which is invasive to animals and may pose risks.

The current situation regarding the limited and unsafe treatment options for animal tumors is worrying. Regarding the limited treatment options, current methods mainly rely on traditional approaches such as surgery, chemotherapy, and radiotherapy. Surgical treatment can be high-risk and invasive, especially for elderly, frail animals or those with tumors in unusual locations, where surgery is not always a viable option. While chemotherapy is effective for some tumors, it often causes side effects such as vomiting, diarrhea, and weakened immunity, impacting the animal's quality of life. Radiotherapy requires specialized equipment and techniques, and this treatment is not available in all regions.

Nanjing Zhenchong Animal Tumor Microwave Ablation System Debuts at the Asian Crafts Conference

The debut of Nanjing Zhenchong's animal tumor microwave ablation system at the first Asian Small Animal Tumor Conference was indeed remarkable.

This mature technology, widely used in human medicine, offers numerous significant advantages. First, its minimally invasive nature greatly reduces trauma to the animal's body. Compared to traditional surgical methods, less trauma means faster postoperative recovery, allowing the animal to return to its normal life more quickly and reducing its pain and discomfort. The minimal bleeding also strongly guarantees the safety of the surgery, lowering surgical risks.

The safe and repeatable nature of these surgeries provides more treatment opportunities for small animals with complex conditions or those prone to relapse. The simplicity of the procedure allows veterinarians to perform surgery more efficiently, shortening operation time and reducing stress on the animals during the procedure. Fewer side effects improve the animals' quality of life and avoid excessive adverse effects from treatment.

Highly targeted treatment ensures precision, enabling more effective ablation of tumor tissue and minimizing damage to surrounding healthy tissue. The low post-operative recurrence rate further gives pet owners hope and greater confidence in their animal's recovery.

In conclusion, Nanjing Zhenchong's animal tumor microwave ablation system has opened up new avenues for the treatment of tumors in small animals and is expected to play an important role in future veterinary clinical practice, bringing good news to countless sick small animals.

Professor Dong Jun visited the booth and provided guidance.

Professor Dong and Teacher Guo

On the second day of the exhibition, Professor Dong Jun personally visited our booth to learn about our tumor microwave ablation system and engaged in in-depth and constructive discussions with Mr. Guo from the marketing department. Among various tumor treatment methods, Professor Dong highly praised our company's microwave ablation technique. Both parties discussed some untapped disease areas and treatment details that need improvement. Finally, they agreed to jointly promote animal tumor diagnosis and treatment, benefiting more pets and pet owners, while also providing veterinarians with an additional, highly effective tumor treatment method.

This Asian symposium has brought new opportunities and challenges to the field of animal tumor treatment. I believe that with everyone's joint efforts, animal tumor diagnosis and treatment will achieve even more remarkable results.